BUZZ-Moderate US flu season supportive for NZ's Fisher & Paykel, Jefferies says
Reuters
Feb 10
BUZZ-Moderate US flu season supportive for NZ's Fisher & Paykel, Jefferies says
** Jefferies says, with current U.S. flu season largely progressing as expected, it helps Fisher & Paykel Healthcare FPH.NZ meet its FY26 guidance
** New Zealand-based medical equipment maker manufactures products for use in acute and chronic respiratory care and has operations in the U.S.
** Jefferies notes the CDC continues to expect a moderate 2025-26 season, but flags elevated flu incidence amongst children
** Brokerage also notes co's estimate that less than 5% of its hospital business is attributable to seasonal effects
** Stock up 4.1% so far this year, as of last close
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.